Paper2297774
Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A and 3 others. Cancer Res, 1990. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue. Papers, record 2297774. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2297774
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Neoplasm | Major topic |
| Colorectal Neoplasms | Major topic |
| Glycoproteins | Major topic |
| Stomach Neoplasms | Major topic |
| Adenocarcinoma | |
| Humans | |
| Lung |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34950576 | Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action. | Front Oncol | 2021 | https://conductscience.org/library/papers/34950576 | PubMed |
| 32368864 | Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer. | Cancer Med | 2020 | https://conductscience.org/library/papers/32368864 | PubMed |
| 28344808 | Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer. | J Immunother Cancer | 2017 | https://conductscience.org/library/papers/28344808 | PubMed |
| 25727152 | Glycosylation alterations in lung and brain cancer. | Adv Cancer Res | 2015 | https://conductscience.org/library/papers/25727152 | PubMed |
| 24175669 | Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice. | Bioconjug Chem | 2013 | https://conductscience.org/library/papers/24175669 | PubMed |
| 21461170 | Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. | Transl Oncol | 2011 | https://conductscience.org/library/papers/21461170 | PubMed |
| 19718796 | Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. | Mol Pharm | 2009 | https://conductscience.org/library/papers/19718796 | PubMed |
| 8384409 | Carcinomas of Bartholin's gland. Histogenesis and the etiological role of human papillomavirus. | Am J Pathol | 1993 | https://conductscience.org/library/papers/8384409 | PubMed |
| 8367454 | Secretion of a single-gene-encoded immunoglobulin from myeloma cells. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8367454 | PubMed |
| 8270610 | High-affinity chimeric anti-(colorectal carcinoma) antibody correlated to enhanced tumor targeting in biodistribution and imaging. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8270610 | PubMed |
| 7508339 | Epitope masking of rat esophageal carcinoma tumor-associated antigen by certain coexisting glycolipid and phospholipid molecules: a potential mechanism for tumor cell escape from the host immune responses. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/7508339 | PubMed |
| 2248992 | Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications. | Biophys J | 1990 | https://conductscience.org/library/papers/2248992 | PubMed |
| 1597401 | Targeting antibodies to live tumor tissue in 3-D histoculture. | In Vitro Cell Dev Biol | 1992 | https://conductscience.org/library/papers/1597401 | PubMed |
| 1551684 | Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody. | Immunology | 1992 | https://conductscience.org/library/papers/1551684 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2297774
GET https://conductscience.org/api/papers/v1/2297774/authors